This transcript is automatically generated
-- -- from their share for a moment is the latest legislation president Obama's we can't wait campaign.
A real prescription to fix the drug shortage that we have here in the United States.
The wall street journal editorial page opinion this morning says no and managing editor for Fox News health dot com Dr.
Manny Alvarez.
It's certainly agrees -- mean.
I said at first yes you have that I said -- first I wrote about it immediately.
Look medication shortages a problem that has been growing now for several several years went quick thought about just what we did we get a first here Fox Business.
And when this -- came out of the presence.
Speech the other day that they have basically just tells pharmaceutical companies to go ahead and notify us within six months and this is gonna take care of the problem -- -- are you kidding me this is a this is that show although politics rather than a policy and of course he circumvented.
The congress.
But.
This is not gonna change anything because the problem and this is already been identified by the FDA the problem would is.
Manufacturing standards that are very rigid very tough and there are technical issues there.
Supply -- of the -- materials that are now not readily available.
The tremendous cause of research and development of pharmaceutical companies have to -- ago.
And then that all over utilization by consumers especially no one of the many drugs that get affected our ER drugs you know emerges from drugs.
For a lot of folks out there you know -- for the last decade or so they look at the emergency room.
As a primary care clinic so they have a headache people get that treatment they have they have a they'd be you know -- little dehydrated it will get there right me.
And they -- marshals as they go there and -- -- altering the emergency room as -- -- -- -- -- -- as the prime acres additional.
With all of these issues you'll never resolve the problem my basic view.
No -- thick Salt -- points out into what's the not quick -- absolutely not just a combination of everything you talked about yeah you gotta look you got to sit down you've got to create policies.
You got -- do you regulate the industry a lot because I think that there's a lot of over regulation.
And especially -- the FDA level when he comes to -- you know biotechnology and pharmaceutical companies you know.
Litigation adapted to show much research to -- the side effects of some think.
That it's impossible to bring these -- Natalie -- market ice caps which I don't last administration put in place for the Easter -- That's why there's a huge difference between Europeans and the Canadians when it comes to these types of regulation.
And -- biotechnology industry is a lot of as is is very different.
-- -- send along your passion.
Thank you -- had a lot of cash and and Dr.
Manny will be on Imus in the morning tomorrow -- might like to you know I woke up this morning at 5 o'clock with the photos today will good he should be alright.
The only way and I like fifty up I'm gonna be very afraid be on top of that man behind reality going to be that the better than our study in how I got I got my -- -- notes we'll see in the morning you got it documented --